Meetup booth information has been released！（4/11）
Speaker information has been updated!（4/７）
Online registration for participation is now open (3/25)
Daiichi Sankyo Co., Ltd. has joined the pharmaceutical company presentation part !(3/4)
LINK-J Conference 2025 -R&D x Investment-” will be held on May 10, 2025 at Muromachi Mitsui Hall & Conference as the second edition of LINK-J's new large-scale conference ‘LINK-J Conference -R&D x Investment-’, which received a favorable response last year.LINK-J Conference 2025 -R&D x Investment-” will be held on May 10, 2025 at Muromachi Mitsui Hall & Conference.
We will have several programs including presentations by key persons and fireside chats among speakers as well as lectures on research strategies by top executives of R&D divisions of major Japanese pharmaceutical companies.
This is a must-attend program for pharmaceutical companies, drug discovery start-ups, investors, and others.
Networking time will also be available along with a standing reception with food and beverages. Please come to Tokyo Nihonbashi to learn about the latest information and cutting-edge technologies from Japan's pharmaceutical companies, and take advantage of this opportunity to discuss how to strengthen the ecosystem of the Japanese pharmaceutical industry for the overseas market.
We look forward to seeing you there.
Language:Japanese and English *Simultaneous interpretation is available
Registration due date
Application Deadline
Until 17:00 on Wednesday, April 30, 2025
*If you wish to pay at a convenience store / ATM, please do so by 9:00 a.m. on Thursday, May 1, 2025.
*Be sure to apply before the application deadline.
Regarding Receipts
*Once payment is confirmed, a receipt and an attendance record can be issued from My Page. Please note that it may take some time for the receipt to be reflected.
Program
| Time | Program |
| 10:00‐11:45 Session 1: Opening Remarks, Keynote Speeches, Fireside Chat | |
| 10:05‐10:15 | Opening & Purpose Explanation Shunichi Takahashi, President & COO, LINK-J |
| 10:15‐10:45 | Keynote Speech 1 Daisuke Yoshizumi, Head of Healthcare, Japan, J.P. Morgan Securities Co., Ltd. |
| 10:45‐11:05 | Keynote Speech 2 Johannes Fruehauf, PhD, MD, Founder and President, BioLabs Global Inc. |
| 11:05‐11:45 | Fireside Chat１ TBD |
| 11:45‐12:45 Lunch Break | |
| 11:45‐12:45 | Special Program (TBD) |
| 12:45‐13:00 | Break |
| 13:00-15:20 Session 2: Pharmaceutical Company Presentations, Fireside Chat | |
| 13:00‐13:25 | Speech 1 Teiji Wada, Head of Research Innovation Planning Department, Daiichi Sankyo Co., Ltd. |
| 13:25‐13:45 | Speech 2 Takashi Owa, Senior Group Officer, External Innovation, DHBL, Eisai Co., Ltd. |
| 13:45‐14:05 | Speech 3 Hide Goto, Head of Open Innovation Japan, Astellas Pharma Inc. |
| 14:05‐14:25 | Speech 4 Isao Shimizu, Executive Officer, Deputy Head of R&D Headquarters (Drug Discovery Research), Sumitomo Pharma Co., Ltd. |
| 14:25‐15:05 | Fireside Chat２ TBD |
| 15:05‐15:20 | Break |
| 15:20‐17:35 Session 3: Keynote Speech, Pharmaceutical Company Presentations, Fireside Chat | |
| 15:20‐15:50 | Keynote Speech 3 Takanori Takebe, Professor, Graduate School of Medicine, The University of Osaka Professor, Institute of Integrated Research, Institute of Science Tokyo Director, Communication Design Center, Yokohama City University Associate Professor, Director of Commercial Innovation, Center for Stem Cell & Organoid Medicine, Cincinnati Children’s Hospital Medical Center |
| 15:50‐16:10 | Speech 5 Yasushi Kajii, R&D Japan Region Head, Takeda Pharmaceutical Co., Ltd. |
| 16:10‐16:30 | Speech 6 Hitoshi Iikura, Director, Executive Vice President, Chugai Pharmaceutical Co., Ltd. |
| 16:30‐16:50 | Speech 7 Kazuhito Yamada, Head of Product Research Department, Santen Pharmaceutical Co., Ltd. |
| 16:50‐17:30 | Fireside Chat３ Takanori Takebe Hitoshi Iikura Yasushi Kajii Tai harada, Partner, Fast Track Initiative moderated by Aya Kubota, Editor in Chief Nikkei Biotechnology & Business |
| 17:30‐17:35 | Closing TBD |
| 17:35-18:30 Networking Reception | |
| 17:35-18:30 | Reception |
*Honorifics omitted.
*The program is subject to change without notice. Please note that the program is subject to change without notice.
LINK-J Member Meetup Booth
We will have an exhibition booth at the venue! Please come and visit us!
| Booth | |
| Biomy, Inc |  |
| BioPhenoMA Inc. |  |
| Elix, Inc. | .png) |
| EnmeiPro K.K. |  |
| iXgene Inc. | .png) |
| SyntheticGestalt KK |  |
| ASCA Corporation |  |
| Amelieff Corporation |  |
| Emerging Technologies Corporation |  |
| OOSUMI LOGISTICS CO., LTD. |  |
| SYSMEX CORPORATION | .png) |
| The Japan Pharmaceutical Manufacturers Association (JPMA) |  |
| Novogene Japan K.K. |  |
| Beckman Coulter K.K. | .png) |
| Macromill Carenet, Inc. |  |
| Metcela Inc. |  |
| RIKEN GENESIS CO., LTD. |  |
Target
pharmaceutical companies, drug discovery start-ups, investors, and others.
Participation Fee
After March 25, 2025
On-site Participation Fee:(member)8,000YEN （non-member)40,000YEN
On-line Participation Fee:(member) 0YEN （non-member)40,000YEN
Regarding EalryBird registration
EalryBird registration is now closed.No discounts will be offered after the deadline, so please register as soon as possible.
Capacity
On-site 50persons,Online 1000persons
Pre-registration is required to attend. Please note that registration will be on a first-come, first-served basis.
Organizer
Host by LINK-J
Supported by
Forum for Innovative Regenerative Medicine（FIRM）
Japan Pharmaceutical Manufacturers Association（JPMA）
Greater Tokyo Biocommunity（GTB）
Biocommunity Kansai(BiocK)
Sponsored by
Japan Agency for Medical Research and Development(AMED)
Contact
LINK-J Symposium secretariat（JTB Communication Design, Inc.）
Yumi Hynes・Tomochika
E-mail：linkj-sympo@jtbcom.co.jp
